The current financial score of CVS Health Corp is 5.42. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 106.10B, representing a year-over-year increase of 7.26%, while its net profit experienced a year-over-year increase of 191.77%.
The current valuation score of CVS Health Corp is 8.91. Its current P/E ratio is 40.69, which is 448.45% below the recent high of 223.18 and 76.93% above the recent low of 9.39.
The current earnings forecast score of CVS Health Corp is 8.29. The average price target is 112.25, with a high of 125.00 and a low of 79.00.
The current price momentum score of CVS Health Corp is 3.59. Currently, the stock price is trading between the resistance level at 97.73 and the support level at 86.70, making it suitable for range-bound swing trading.
The current institutional shareholding score of CVS Health Corp is 10.00. The latest institutional shareholding proportion is 90.28%, representing a quarter-over-quarter decrease of 1.19%.
No risk assessment score is currently available for CVS Health Corp. The Healthcare Providers & Services industry's average is 5.78. The company's beta value is 0.62. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.